New study tracks Larotrectinib's Real-World impact on rare cancers

This study looks at how well larotrectinib works and how safe it is for people with advanced or returning TRK fusion cancer. It includes both adults and children whose cancer has spread or come back. Researchers will collect information from medical records and doctor visits to see how patients respond to the drug over time.